Guiding the osteogenic fate of mouse and human mesenchymal stem cells through feedback system control

Scientific Reports

Volumn 3, Issue , 2013, Pages

  Honda, Yoshitomo ^a,b,c   Ding, Xianting ^d,e   Mussano, Federico ^a,f   Wiberg, Akira ^a   Ho, Chih Ming ^d   Nishimura, Ichiro ^a  

^a UCLA SCHOOL OF DENTISTRY   (United States)

^b TOHOKU UNIVERSITY   (Japan)

^c OSAKA DENTAL UNIVERSITY   (Japan)

^d Engineering IV   (United States)

^e SHANGHAI JIAO TONG UNIVERSITY   (China)

^f UNIVERSITY OF TURIN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN; CULTURE MEDIUM; SMAD PROTEIN;

ANIMAL; BIOLOGICAL MODEL; BONE DEVELOPMENT; CELL DIFFERENTIATION; CHEMISTRY; CULTURE MEDIUM; CYTOLOGY; DRUG EFFECTS; HUMAN; MESENCHYMAL STROMA CELL; METABOLISM; MOUSE; PHARMACOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; BONE MORPHOGENETIC PROTEINS; CELL DIFFERENTIATION; CULTURE MEDIA; HUMANS; MESENCHYMAL STROMAL CELLS; MICE; MODELS, BIOLOGICAL; OSTEOGENESIS; SIGNAL TRANSDUCTION; SMAD PROTEINS;

EID: 84890091561     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep03420     Document Type: Article

References (47)

1. Colman, A. & Dreesen, O. Pluripotent stem cells and disease modeling. Cell stem cell 5, 244-247 (2009).
2. Augello, A., Kurth, T. B. & De Bari, C. Mesenchymal stem cells: a perspective from in vitro cultures to in vivo migration and niches. Eur Cell Mater 20, 121-133 (2010).
3. Rodriguez, J. P., Montecinos, L., Rios, S., Reyes, P. & Martinez, J. Mesenchymal stem cells from osteoporotic patients produce a type I collagen-deficient extracellular matrix favoring adipogenic differentiation. J Cell Biochem 79, 557-565 (2000).
4. Liu, Y. et al. Intracellular VEGF regulates the balance between osteoblast and adipocyte differentiation. J Clin Invest 122, 3101-3113 (2012).
5. Szpalski, C., Barbaro, M., Sagebin, F. & Warren, S. M. Bone tissue engineering: current strategies and techniques-part II: Cell types. Tissue Eng Part B Rev 18, 258-269 (2012).
6. Mohal, J. S., Tailor, H. D. & Khan, W. S. Sources of adult mesenchymal stem cells and their applicability for musculoskeletal applications. Curr Stem Cell Res Ther 7, 103-109 (2012).
7. Brey, D. M. et al. High-throughput screening of a small molecule library for promoters and inhibitors of mesenchymal stem cell osteogenic differentiation. Biotechnol Bioeng 108, 163-174 (2011).
8. Alves, H., Dechering, K., Van Blitterswijk, C. & De Boer, J. High-throughput assay for the identification of compounds regulating osteogenic differentiation of human mesenchymal stromal cells. PLoS One 6, e26678 (2011).
9. Hoemann, C. D., El-Gabalawy, H. & McKee, M. D. In vitro osteogenesis assays: influence of the primary cell source on alkaline phosphatase activity and mineralization. Pathol Biol 57, 318-323 (2009).
10. Hsiong, S. X., Boontheekul, T., Huebsch, N. & Mooney, D. J. Cyclic arginine-glycine-aspartate peptides enhance three-dimensional stem cell osteogenic differentiation. Tissue Eng Part A 15, 263-272 (2009).
11. Kim, H. K. et al. Red light of 647 nm enhances osteogenic differentiation in mesenchymal stem cells. Lasers Med Sci 24, 214-222 (2009).
12. Siddappa, R. et al. cAMP/PKA signaling inhibits osteogenic differentiation and bone formation in rodent models. Tissue Eng Part A 15, 2135-2143 (2009).
13. Zhao, B. et al. Heparin potentiates the in vivo ectopic bone formation induced by bone morphogenetic protein-2. J Biol Chem 281, 23246-23253 (2006).
14. Zehentner, B. K., Leser, U. & Burtscher, H. BMP-2 and sonic hedgehog have contrary effects on adipocyte-like differentiation of C3H10T1/2 cells. DNA Cell Biol 19, 275-281 (2000). (Pubitemid 30612524)
15. Sottile, V. & Seuwen, K. Bone morphogenetic protein-2 stimulates adipogenic differentiation of mesenchymal precursor cells in synergy with BRL 49653 (rosiglitazone). FEBS Lett 475, 201-204 (2000). (Pubitemid 30408453)
16. Liu, F. et al. A human Mad protein acting as a BMP-regulated transcriptional activator. Nature 381, 620-623 (1996). (Pubitemid 26177480)
17. Massague, J., Seoane, J. & Wotton, D. Smad transcription factors. Genes Dev 19, 2783-2810 (2005). (Pubitemid 41739965)
18. Hata, K. et al. Differential roles of Smad1 and p38 kinase in regulation of peroxisome proliferator-activating receptor gamma during bone morphogenetic protein 2-induced adipogenesis. Mol Biol Cell 14, 545-555 (2003). (Pubitemid 36237015)
19. Wozney, J. M. et al. Novel regulators of bone formation: molecular clones and activities. Science 242, 1528-1534 (1988). (Pubitemid 19023695)
20. Chen, G., Deng, C. & Li, Y. P. TGF-beta and BMP signaling in osteoblast differentiation and bone formation. Int J Biol Sci 8, 272-288 (2012).
21. Lin, G. L. & Hankenson, K. D. Integration of BMP, Wnt, and notch signaling pathways in osteoblast differentiation. J Cell Biochem 112, 3491-3501 (2011).
22. Osyczka, A. M. & Leboy, P. S. Bone morphogenetic protein regulation of early osteoblast genes in human marrow stromal cells is mediated by extracellular signal-regulated kinase and phosphatidylinositol 3-kinase signaling. Endocrinology 146, 3428-3437 (2005). (Pubitemid 41058115)
23. Wang, Y. K. et al. Bone morphogenetic protein-2-induced signaling and osteogenesis is regulated by cell shape, RhoA/ROCK, and cytoskeletal tension. Stem Cells Dev 21, 1176-1186 (2012).
24. Mussano, F. et al. Differential effect of ionizing radiation exposure on multipotent and differentiation-restricted bone marrow mesenchymal stem cells. J Cell Biochem 111, 322-332 (2010).
25. Bais, M. V. et al. BMP2 is essential for post natal osteogenesis but not for recruitment of osteogenic stem cells. Bone 45, 254-266 (2009).
26. Javed, A. et al. Structural coupling of Smad and Runx2 for execution of the BMP2 osteogenic signal. J Biol Chem 283, 8412-8422 (2008).
27. Anderson, G. J. & Darshan, D. Small-molecule dissection of BMP signaling. Nat Chem Biol 4, 15-16 (2008). (Pubitemid 350273659)
28. Ding, X. et al. Cascade search for HSV-1 combinatorial drugs with high antiviral efficacy and low toxicity. Int J Nanomedicine 7, 2281-2292 (2012).
29. Sun, C. P. et al. Integrative systems control approach for reactivating Kaposi's sarcoma-associated herpesvirus (KSHV) with combinatory drugs. Integr Biol (Camb) 1, 123-130 (2009).
30. Tsutsui, H. et al. An optimized small molecule inhibitor cocktail supports longterm maintenance of human embryonic stem cells. Nat Commun 2, 167 (2011).
31. Komori, T. et al. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 89, 755-764 (1997). (Pubitemid 27516178)
32. Otto, F. et al. Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell 89, 765-771 (1997). (Pubitemid 27516179)
33. Nakashima, K. et al. The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell 108, 17-29 (2002). (Pubitemid 34137009)
34. Franceschi, R. T., Ge, C., Xiao, G., Roca, H. & Jiang, D. Transcriptional regulation of osteoblasts. Ann N Y Acad Sci 1116, 196-207 (2007). (Pubitemid 350274351)
35. De Biase, P. & Capanna, R. Clinical applications of BMPs. Injury 36 Suppl 3, S43-46 (2005).
36. Shimer, A. L., Oner, F. C. & Vaccaro, A. R. Spinal reconstruction and bone morphogenetic proteins: open questions. Injury 40 Suppl 3, S32-38 (2009).
37. Diefenderfer, D. L., Osyczka, A. M., Reilly, G. C. & Leboy, P. S. BMP responsiveness inhuman mesenchymal stem cells. Connect Tissue Res44Suppl 1, 305-311 (2003). (Pubitemid 36395462)
38. Osyczka, A. M., Diefenderfer, D. L., Bhargave, G. & Leboy, P. S. Different effects of BMP-2 on marrow stromal cells from human and rat bone. Cells Tissues Organs 176, 109-119 (2004). (Pubitemid 38199424)
39. Sierra, J. et al. Regulation of the bone-specific osteocalcin gene by p300 requires Runx2/Cbfa1 and the vitamin D3 receptor but not p300 intrinsic histone acetyltransferase activity. Mol Cell Biol 23, 3339-3351 (2003). (Pubitemid 36459245)
40. Jorgensen, N. R., Henriksen, Z., Sorensen, O. H. & Civitelli, R. Dexamethasone, BMP-2, and 1, 25-dihydroxyvitamin D enhance a more differentiated osteoblast phenotype: validation of an in vitro model for human bone marrow-derived primary osteoblasts. Steroids 69, 219-226 (2004). (Pubitemid 38748717)
41. Yuan, W. et al. 1, 25-dihydroxyvitamin D3 suppresses renin gene transcription by blocking the activity of the cyclic AMP response element in the renin gene promoter. J Biol Chem 282, 29821-29830 (2007). (Pubitemid 350035242)
42. Kato, S., Fujiki, R., Kim, M. S. & Kitagawa, H. Ligand-induced transrepressive function of VDR requires a chromatin remodeling complex, WINAC. J Steroid Biochem Mol Biol 103, 372-380 (2007). (Pubitemid 46401329)
43. Egawa, N. et al. Drug screening for ALS using patient-specific induced pluripotent stem cells. Sci Transl Med 4, 145ra104 (2012).
44. Tanaka, T.etal. Induced pluripotent stem cells from CINCA syndrome patients as a model for dissecting somatic mosaicism and drug discovery. Blood 120, 1299-1308, 2012
45. Quarto, N. et al. Skeletogenic phenotype of human Marfan embryonic stem cells faithfully phenocopied by patient-specific induced-pluripotent stem cells. Proc Natl Acad Sci U S A 109, 215-220 (2012).
46. Cai, J., Pardali, E., Sanchez-Duffhues, G. & ten Dijke, P. BMP signaling in vascular diseases. FEBS Lett 586, 1993-2002 (2012).
47. Csiszar, A., Labinskyy, N., Jo, H., Ballabh, P. & Ungvari, Z. Differential proinflammatory and prooxidant effects of bone morphogenetic protein-4 in coronary and pulmonary arterial endothelial cells. Am J Physiol Heart Circ Physiol 295, H569-577 (2008).